Efficacy and Safety of Canakinumab in a Large Cohort of Cryopyrin-Associated Periodic Syndrome (CAPS) Patients across All Severity Phenotypes.
R. Cartwright, J. Smith, P. Hawkins, J. Kuemmerle-Deschner, E. Hachulla, I. Kone-Paut, J. Hoyer, P. Quartier, M. Gattorno, A. Widmer, N. Patel, R. Preiss, K. Leslie
PMID: